MRSA fears increasing public awareness of Molluscum Contagiosum
CHARLES TOWN, W.V., Nov 26 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum today announced record breaking sales for the month of October 2007; increase is 12% above previous record which was set in September 2007.
“As public awareness of the dangers related to MRSA infections climb, treating Molluscum Contagiosum quickly and noninvasively has become imperative,” says David Phillips, Ph.D. CEO. “Our record sales reflect our response to the needs of our customers by providing safe, effective alternatives to the burning, freezing, and cutting methods used by physicians that can create an increased risk for opportunistic infections like MRSA.”
“We are seeing sales growth across all of our product lines. Our continuing innovation is placing us ahead of the curve. We will be releasing more news about our company’s plans for expansion this week,” says Dr. Phillips.
For more information visit: www.rebuildermedical.com and www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,
+1-304-725-2202
